disease 1,178 words KG: ent-dise-e2fc47b9
Contents

Early-Onset Alzheimer's Disease (EOAD)

Disease Info
Under 50 yearsVery rare, primarily genetic forms
50-59 years~1% of AD cases
60-64 years~5-10% of AD cases
Down syndromeTrisomy 21 leads to APP overexpression; ~50% develop AD by age 60[^6]
Head traumaHistory of traumatic brain injury increases risk
Cardiovascular risk factorsDiabetes, hypertension, hypercholesterolemia
EducationLower educational attainment associated with earlier onset
Posterior cortical atrophy (PCA)Visual processing deficits, often mistaken for ocular disease[^8]
Logopenic aphasiaLanguage-dominant presentation with word-finding difficulties
Behavioral variant FTD-likePersonality changes, disinhibition (can be PSEN1-related)
Corticobasal syndromeMotor symptoms with asymmetric rigidity
Average delay2-3 years from symptom onset to diagnosis
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (28)

Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.95
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.89
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.78
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.74
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.68
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.67
Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli
Score: 0.67
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
LRP1-Dependent Tau Uptake Disruption
Score: 0.60
VCP-Mediated Autophagy Enhancement
Score: 0.59
Extracellular Vesicle Biogenesis Modulation
Score: 0.58
Synaptic Vesicle Tau Capture Inhibition
Score: 0.58
HSP90-Tau Disaggregation Complex Enhancement
Score: 0.57
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.54
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
pg 1/2Next →

Related Analyses (24)

Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Meta-analysis of physical activity interventions on cognitiv
clinical · proposed · Score: 0.95
KEEPS Continuation: Long-term effects of menopausal hormone
clinical · proposed · Score: 0.95
Dairy intake and dementia risk in Malmö Diet and Cancer coho
clinical · proposed · Score: 0.95
GWAS of plasma pTau217 in East Asian cohort
exploratory · proposed · Score: 0.95

See Also (15)

ASL Perfusion Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
Digital Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
Dried Blood Spot Biomarker Test for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
DTI Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
EEG Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.